IO INFORMATICS ANNOUNCES APPOINTMENT OF KATHY GIBSON TO BOARD OF DIRECTORS
BERKELEY, CA - April 17, 2009.
IO Informatics (IOI), a leader in data integration and semantic technology-based knowledge applications for the Life Science and Healthcare industries, today announced the appointment of Kathy Gibson to its Board of Directors. Ms. Gibson brings more than 13 years of senior level life science informatics expertise to IOI.
Ms. Gibson has recently formed Helio Consulting (www.helioconsulting.com) whose mission is to provide advice and consultation on how best to identify and implement innovation across a spectrum of industries. Prior to forming Helio Consulting, she held a variety of positions with Pfizer Worldwide, including CIO for Research, VP Business Innovation and Global Head, Advanced Research Technologies. She has focused her career at Pfizer tackling some of Research and Development’s toughest challenges in the areas of productivity, business efficiency, change management and innovation by applying industry knowledge along with a solid background as a technologist.
“I am enthusiastic about IOI’s promise and about the contribution I see making as a Director,” Kathy commented. “The technology and team are already improving life science research and development, and are positioned to contribute to the next, practical phase for predictive biology and personalized medicine. I’m particularly impressed by their unique ability to create and apply knowledge models using semantic technology,” she added.
Bob Stanley, CEO of IOI, commenting on Ms. Gibson’s appointment to the IOI Board said, “We are delighted to have Kathy join our Board. She brings a wealth of experience in Life Science informatics and has a sharp focus in technology and its impact on the bottom line for business innovation. Her advice and counsel will be valuable as we continue to grow our current customer base and expand our software and solution offerings. I’m impressed and excited by her vision and our shared goals towards contributing transformational value to life science and healthcare through IOI’s advanced informatics framework and knowledge applications.”
Ms. Gibson and IOI first began working together on the PROOF initiative for presymptomatic detection of risks for organ failure, out of Dr. Bruce McManus’s iCapture Institute (http://www.icapture.ubc.ca). Kathy recently joined a number of industry leaders on IOI’s Personalized Medicine Working Group (http://www.io-informatics.com/company/working-groups.html#PersMedicine) whose focus is on informatics knowledge applications produced by connecting life sciences informatics and the point of care.
About IO Informatics
IOI is at the forefront of a global revolution in software for data integration and knowledge applications. It’s Semantically-enabled SentientTM software suite allows life science, biotechnology, pharmaceutical, and medical researchers to structure & define complex data relationships across data sources, view these relationships, query them, and capitalize on them - all within a secure, compliant, auditable framework that helps organizations accumulate and leverage knowledge. Founded in 2003, IO Informatics is headquartered in Berkeley, California (www.io-informatics.com).